Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04224389

IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas

Prospective Non-randomized Comparative Study Between IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas of Early Local Stage of Oropharynx

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Compare patients' feelings in terms of swallowing ability assessed by the overall score of MD Anderson Dysphagia Inventory (MDADI) 2 years after starting treatment between patients who have been treated with IMRT and those who were treated by transoral surgery for a squamous cell carcinoma of the early stage oropharynx.

Conditions

Interventions

TypeNameDescription
PROCEDUREtransoral resectionThe technique of transoral surgery will be left to the choice of the surgeon according to the equipment and the experience of the team and will be gathered. The options are: transoral surgery robot-assisted, endoscopic laser transoral surgery, transoral laser surgery classical instruments. The exact description of the resected area will be collected. of the cross-sections will be made for extemporaneous analysis if necessary in lateral margins and deep until complete excision.
RADIATIONIMRTIntensity modulation radiotherapy (RCMI or IMRT) will be performed using techniques static or rotational (arctherapy, tomotherapy). Restraint is recommended with thermoformed mask

Timeline

Start date
2018-06-22
Primary completion
2031-06-01
Completion
2031-06-01
First posted
2020-01-13
Last updated
2025-05-08

Locations

16 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04224389. Inclusion in this directory is not an endorsement.